<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-HYP24P0D</identifier><date>2016</date><creator>Bricl, Irena</creator><creator>Hrašovec-Lampret, Andreja</creator><relation>documents/doc/H/URN_NBN_SI_doc-HYP24P0D_001.pdf</relation><relation>documents/doc/H/URN_NBN_SI_doc-HYP24P0D_001.txt</relation><format format_type="issue">4</format><format format_type="volume">85</format><format format_type="type">article</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">286456064</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-HYP24P0D</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">eritrocitna aloprotitelesa</subject><subject language_type_id="eng">human pregnancy</subject><subject language_type_id="slv">nosečnost</subject><subject language_type_id="slv">protitelesa</subject><subject language_type_id="slv">senzibilizacija</subject><title>Izdaja po Kellu skladnih krvnih komponent z namenom preprečiti anti-K senzibilizacijo pri ženskah v rodni dobi</title><title>Selecting K compatible blood components for transfusion can prevent anti-K immunization in women of childbearing age</title></Record>